Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Mallinckrodt
Medtronic
AstraZeneca
Express Scripts

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR CLOZARIL


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Clozaril

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00042224 ↗ Electroconvulsive Therapy in Clozapine Refractory Schizophrenia Completed National Institute of Mental Health (NIMH) Phase 1/Phase 2 2000-12-01 This study will evaluate electroconvulsive therapy (ECT) in patients who have not responded adequately to clozapine.
NCT00042224 ↗ Electroconvulsive Therapy in Clozapine Refractory Schizophrenia Completed Northwell Health Phase 1/Phase 2 2000-12-01 This study will evaluate electroconvulsive therapy (ECT) in patients who have not responded adequately to clozapine.
NCT00154258 ↗ A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia Completed Novartis Phase 2 2001-04-01 Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.
NCT00169091 ↗ Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia Terminated Commonwealth Research Center, Massachusetts Phase 4 1996-03-01 This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
NCT00169091 ↗ Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia Terminated Dartmouth-Hitchcock Medical Center Phase 4 1996-03-01 This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
NCT00169091 ↗ Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia Terminated National Institute of Mental Health (NIMH) Phase 4 1996-03-01 This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
NCT00169091 ↗ Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia Terminated Novartis Phase 4 1996-03-01 This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Clozaril

Condition Name

Condition Name for Clozaril
Intervention Trials
Schizophrenia 18
Schizoaffective Disorder 8
Bipolar Disorder 2
Psychotic Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Clozaril
Intervention Trials
Schizophrenia 19
Psychotic Disorders 10
Disease 6
Mental Disorders 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Clozaril

Trials by Country

Trials by Country for Clozaril
Location Trials
United States 23
Canada 4
Korea, Republic of 3
Japan 1
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Clozaril
Location Trials
California 3
Massachusetts 3
New York 3
New Hampshire 3
North Carolina 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Clozaril

Clinical Trial Phase

Clinical Trial Phase for Clozaril
Clinical Trial Phase Trials
Phase 4 11
Phase 3 1
Phase 2 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Clozaril
Clinical Trial Phase Trials
Completed 12
Recruiting 3
Not yet recruiting 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Clozaril

Sponsor Name

Sponsor Name for Clozaril
Sponsor Trials
National Institute of Mental Health (NIMH) 5
Dartmouth-Hitchcock Medical Center 4
Centre for Addiction and Mental Health 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Clozaril
Sponsor Trials
Other 41
Industry 7
NIH 6
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Moodys
Dow
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.